|
Name |
Prenylterphenyllin
|
| Molecular Formula | C25H26O5 | |
| IUPAC Name* |
2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxyphenyl)-3,6-dimethoxyphenol
|
|
| SMILES |
CC(=CCC1=C(C=CC(=C1)C2=C(C=C(C(=C2O)OC)C3=CC=C(C=C3)O)OC)O)C
|
|
| InChI |
InChI=1S/C25H26O5/c1-15(2)5-6-17-13-18(9-12-21(17)27)23-22(29-3)14-20(25(30-4)24(23)28)16-7-10-19(26)11-8-16/h5,7-14,26-28H,6H2,1-4H3
|
|
| InChIKey |
YEVBMDOXFLFVJJ-UHFFFAOYSA-N
|
|
| Synonyms |
PRENYLTERPHENYLLIN; CHEBI:67533; Prenyltherphenyllin; CHEMBL1795464; DTXSID601315915; BDBM50457902; Q27136002; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxyphenyl)-3,6-dimethoxyphenol; 3',6'-dimethoxy-3-(3-methylbut-2-en-1-yl)-1,1':4',1''-terphenyl-2',4,4''-triol; 959124-85-7
|
|
| CAS | 959124-85-7 | |
| PubChem CID | 23630784 | |
| ChEMBL ID | CHEMBL1795464 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 406.5 | ALogp: | 6.0 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 79.2 | Aromatic Rings: | 3 |
| Heavy Atoms: | 30 | QED Weighted: | 0.45 |
| Caco-2 Permeability: | -4.857 | MDCK Permeability: | 0.00001270 |
| Pgp-inhibitor: | 0.336 | Pgp-substrate: | 0.013 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.826 |
| 30% Bioavailability (F30%): | 0.199 |
| Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 98.95% |
| Volume Distribution (VD): | 0.743 | Fu: | 1.40% |
| CYP1A2-inhibitor: | 0.848 | CYP1A2-substrate: | 0.727 |
| CYP2C19-inhibitor: | 0.957 | CYP2C19-substrate: | 0.065 |
| CYP2C9-inhibitor: | 0.847 | CYP2C9-substrate: | 0.942 |
| CYP2D6-inhibitor: | 0.694 | CYP2D6-substrate: | 0.918 |
| CYP3A4-inhibitor: | 0.448 | CYP3A4-substrate: | 0.377 |
| Clearance (CL): | 9.529 | Half-life (T1/2): | 0.496 |
| hERG Blockers: | 0.085 | Human Hepatotoxicity (H-HT): | 0.135 |
| Drug-inuced Liver Injury (DILI): | 0.753 | AMES Toxicity: | 0.064 |
| Rat Oral Acute Toxicity: | 0.083 | Maximum Recommended Daily Dose: | 0.083 |
| Skin Sensitization: | 0.65 | Carcinogencity: | 0.045 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.572 |
| Respiratory Toxicity: | 0.199 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002776 | ![]() |
0.953 | D06GCK | ![]() |
0.357 | ||
| ENC005867 | ![]() |
0.837 | D0Q9ON | ![]() |
0.333 | ||
| ENC005868 | ![]() |
0.837 | D0Q0PR | ![]() |
0.329 | ||
| ENC002758 | ![]() |
0.787 | D0J7RK | ![]() |
0.295 | ||
| ENC002453 | ![]() |
0.783 | D0AZ8C | ![]() |
0.293 | ||
| ENC005039 | ![]() |
0.742 | D07MGA | ![]() |
0.286 | ||
| ENC002011 | ![]() |
0.720 | D06FOU | ![]() |
0.279 | ||
| ENC000826 | ![]() |
0.663 | D0K8KX | ![]() |
0.277 | ||
| ENC005870 | ![]() |
0.625 | D06KYN | ![]() |
0.276 | ||
| ENC005871 | ![]() |
0.625 | D09ZQN | ![]() |
0.275 | ||